AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 9

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.04 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019654GHRP-2TFCTFC-2502-D2333Medutest2025-Q199.365.2693.0Buyer-sourced1FAIL
AX-2025-019605GHRP-2TFCTFC-2411-A2083Janoshik2025-Q199.761.87—Buyer-sourced0PASS
AX-2025-019373GHRP-2HYBHYB-2501-R7240Janoshik2025-Q199.605.32—Buyer-sourced0PASS
AX-2025-019138TesamorelinGSPGSP-2501-G3708Janoshik2025-Q198.294.52—Buyer-sourced0PASS
AX-2025-018959TirzepatideASYASY-{CAT}-1489Janoshik2025-Q198.626.3598.1Buyer-sourced0PASS
AX-2025-018919CJC-1295 with DACTFSTFS-{CAT}-9795Janoshik2025-Q198.934.0790.8Laboratory-retained2MARGINAL
AX-2025-018848DihexaFGPFGP-2408-S8496Janoshik2025-Q199.157.1897.8Buyer-sourced0PASS
AX-2025-018673TirzepatideQSCQSC-2410-R5814VendorInvestigate2025-Q199.144.8796.8Buyer-sourced0PASS
AX-2025-018434TirzepatideWWBWWB-2411-A2303Janoshik2025-Q198.881.59—Buyer-sourced0PASS
AX-2025-021225BPC-157PPGPPG-2412-N7907Janoshik2025-Q199.754.1492.2Buyer-sourced0PASS
AX-2025-020994CJC-1295 with DACWXTWXT-2409-Y3760Kestrel2025-Q197.826.04—Buyer-sourced1MARGINAL
AX-2025-020505PemvidutideKPKP-2501-G6332Medutest2025-Q198.345.4497.0Buyer-sourced1MARGINAL
AX-2025-019781RetatrutideHomopeptideHOMO-2409-R4202Janoshik2025-Q199.372.63—Buyer-sourced0PASS
AX-2025-019362TirzepatideHYBHYB-2408-R7015Janoshik2025-Q198.475.7797.8Buyer-sourced0PASS
AX-2025-018634TirzepatideQSCQSC-2408-T5296Janoshik2025-Q199.935.67—Buyer-sourced0PASS
AX-2025-021126EpitalonSIGSIG-2412-6325Medutest2025-Q199.417.99—Laboratory-retained0FAIL
AX-2025-020920SermorelinWXTWXT-2411-H2426VendorInvestigate2025-Q197.895.67—Buyer-sourced1FAIL
AX-2025-020518MOTS-cSSASSA-2501-M6154Nordanalyt2025-Q197.952.77104.2Buyer-sourced0FAIL
AX-2025-020293BPC-157GGPepsGGPE-2502-S2559Janoshik2025-Q198.752.74—Buyer-sourced0PASS
AX-2025-019491KPVJEEPJEEP-2410-C8600PeptideMeter2025-Q199.936.0890.6Buyer-sourced0FAIL
AX-2025-019348TirzepatideHYBHYB-2408-W6301PeptideMeter2025-Q198.784.1896.6Buyer-sourced2MARGINAL
AX-2025-019186IGF-1 LR3SinoPepSNP-2411-T4814PeptideMeter2025-Q198.484.2897.0Buyer-sourced0PASS
AX-2025-021162SemaglutidePPGPPG-2408-B6709Janoshik2025-Q198.574.98—Buyer-sourced0PASS
AX-2025-020825ThymalinCPCCPC-2501-V2021VendorInvestigate2025-Q1N/A6.67—Buyer-sourced1N/A
AX-2025-020515MOTS-cSSASSA-2501-M6154PeptideMeter2025-Q198.243.07—Buyer-sourced0PASS
AX-2025-019945AOD-9604HJHJ-2502-E7144Medutest2025-Q198.711.9396.1Buyer-sourced0PASS
AX-2025-019925SelankHJHJ-2501-M6535Janoshik2025-Q199.507.60105.5Buyer-sourced0PASS
AX-2025-019891TirzepatideHJHJ-2501-P5963Janoshik2025-Q198.622.3093.6Buyer-sourced0PASS
AX-2025-019828KPVHomopeptideHOMO-2411-P5026VendorInvestigate2025-Q199.174.84105.2Buyer-sourced0FAIL
AX-2025-018818L-CarnosineFGPFGP-2501-G8414Janoshik2025-Q199.938.48101.0Supplier-supplied0PASS
AX-2025-018817L-CarnosineFGPFGP-2501-G8414Medutest2025-Q199.788.56—Laboratory-retained0PASS
AX-2025-018683TB-500QSCQSC-2411-X6249Janoshik2025-Q199.795.68—Buyer-sourced0PASS
AX-2025-020924PT-141 (Bremelanotide)WXTWXT-2410-M2421Janoshik2025-Q198.405.00—Buyer-sourced0FAIL
AX-2025-020791TB-500CPCCPC-2408-B9995Medutest2025-Q198.775.1699.7Buyer-sourced0PASS
AX-2025-020264Enclomiphene citrateGGPepsGGPE-2410-S2226Janoshik2025-Q198.273.9994.6Buyer-sourced0FAIL
AX-2025-019957TB-500HJHJ-2501-A6454PeptideMeter2025-Q199.484.62—Buyer-sourced1MARGINAL
AX-2025-019803L-Glutathione (reduced)HomopeptideHOMO-2501-D4371Janoshik2025-Q199.938.0893.3Buyer-sourced0PASS
AX-2025-019606GHRP-2TFCTFC-2411-A2083Janoshik2025-Q199.571.74105.7Buyer-sourced0PASS
AX-2025-018740CJC-1295 (no DAC)QSCQSC-2411-D7855Janoshik2025-Q199.043.5392.8Buyer-sourced0PASS
AX-2025-018681TB-500QSCQSC-2411-X6249PeptideMeter2025-Q199.935.8691.5Buyer-sourced1MARGINAL